Deutsche Bank’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.16M Sell
113,321
-388,518
-77% -$18.4M ﹤0.01% 1392
2025
Q4
$25.5M Buy
501,839
+373,381
+291% +$19.1M 0.01% 814
2025
Q3
$7.13M Sell
128,458
-18,334
-12% -$1.07M ﹤0.01% 1162
2025
Q2
$10.1M Sell
146,792
-3,842
-3% -$261K ﹤0.01% 993
2025
Q1
$10.5M Buy
150,634
+2,152
+1% +$178K ﹤0.01% 997
2024
Q4
$12.8M Sell
148,482
-936
-0.6% -$101K 0.01% 953
2024
Q3
$17.8M Sell
149,418
-2,502
-2% -$334K 0.01% 865
2024
Q2
$21.7M Buy
151,920
+1,594
+1% +$211K 0.01% 799
2024
Q1
$19.3M Buy
150,326
+6,183
+4% +$736K 0.01% 828
2023
Q4
$14.9M Buy
144,143
+6,755
+5% +$668K 0.01% 870
2023
Q3
$12.5M Sell
137,388
-670,442
-83% -$59.1M 0.01% 819
2023
Q2
$65.4M Buy
807,830
+691,798
+596% +$56.5M 0.03% 443
2023
Q1
$9.23M Buy
116,032
+1,112
+1% +$78.9K 0.01% 997
2022
Q4
$7.78M Buy
114,920
+15,900
+16% +$932K ﹤0.01% 1060
2022
Q3
$4.93M Sell
99,020
-178,454
-64% -$9.56M ﹤0.01% 1221
2022
Q2
$15.5M Buy
277,474
+146,320
+112% +$8.12M 0.01% 851
2022
Q1
$7.28M Buy
131,154
+4,346
+3% +$223K ﹤0.01% 1225
2021
Q4
$7.1M Sell
126,808
-1,224
-1% -$66.3K ﹤0.01% 1266
2021
Q3
$6.15M Buy
128,032
+20,442
+19% +$988K ﹤0.01% 1395
2021
Q2
$4.51M Sell
107,590
-770
-0.7% -$29.8K ﹤0.01% 1610
2021
Q1
$3.65M Sell
108,360
-21,068
-16% -$750K ﹤0.01% 1749
2020
Q4
$4.52M Sell
129,428
-18,350
-12% -$634K ﹤0.01% 1416
2020
Q3
$5.13M Sell
147,778
-41,442
-22% -$1.38M ﹤0.01% 1249
2020
Q2
$6.2M Buy
189,220
+35,246
+23% +$1.12M ﹤0.01% 1192
2020
Q1
$4.63M Buy
153,974
+5,310
+4% +$158K ﹤0.01% 1293
2019
Q4
$4.3M Sell
148,664
-481,160
-76% -$13.3M ﹤0.01% 1541
2019
Q3
$16.3M Sell
629,824
-14,518
-2% -$367K 0.01% 859
2019
Q2
$16.4M Buy
644,342
+34,496
+6% +$853K 0.01% 1060
2019
Q1
$15.9M Buy
609,846
+135,206
+28% +$3.32M 0.01% 1101
2018
Q4
$10.9M Sell
474,640
-345,092
-42% -$7.67M 0.01% 1245
2018
Q3
$19.3M Sell
819,732
-882,596
-52% -$21.5M 0.01% 1156
2018
Q2
$39.3M Buy
1,702,328
+858,542
+102% +$20.4M 0.02% 777
2018
Q1
$20.8M Buy
843,786
+186,956
+28% +$4.91M 0.01% 1092
2017
Q4
$17.6M Sell
656,830
-63,126
-9% -$1.61M 0.01% 1091
2017
Q3
$17.3M Buy
719,956
+154,724
+27% +$3.5M 0.01% 1124
2017
Q2
$12.1M Sell
565,232
-1,628,768
-74% -$32.9M 0.01% 1258
2017
Q1
$37.6M Buy
2,194,000
+1,668,676
+318% +$29.1M 0.03% 627
2016
Q4
$9.42M Sell
525,324
-802,332
-60% -$14.5M 0.01% 1290
2016
Q3
$27.6M Buy
1,327,656
+836,586
+170% +$20.7M 0.02% 758
2016
Q2
$13.2M Buy
491,070
+323,856
+194% +$8.88M 0.01% 1135
2016
Q1
$4.53M Buy
167,214
+598
+0.4% +$16K ﹤0.01% 1802
2015
Q4
$4.84M Sell
166,616
-112,914
-40% -$3.13M ﹤0.01% 1811
2015
Q3
$7.58M Sell
279,530
-342,836
-55% -$9.71M 0.01% 1485
2015
Q2
$17M Buy
622,366
+448,298
+258% +$12.6M 0.01% 1018
2015
Q1
$4.64M Sell
174,068
-290,120
-63% -$6.68M ﹤0.01% 1839
2014
Q4
$9.82M Buy
464,188
+300,712
+184% +$6.72M 0.01% 1458
2014
Q3
$3.89M Sell
163,476
-648,576
-80% -$14.9M ﹤0.01% 2016
2014
Q2
$18.8M Buy
812,052
+730,192
+892% +$16.1M 0.01% 982
2014
Q1
$1.87M Buy
81,860
+8,480
+12% +$181K ﹤0.01% 2443
2013
Q4
$1.35M Sell
73,380
-445,220
-86% -$7.76M ﹤0.01% 2483
2013
Q3
$8.77M Buy
518,600
+414,430
+398% +$6.97M 0.01% 1411
2013
Q2
$1.61M Buy
+104,170
New +$1.73M ﹤0.01% 2368

Other funds holding NVO

Deutsche Bank's NVO Position: Q1 2026 in Review

Deutsche Bank reduced its Novo Nordisk (NVO) stake by 77% in Q1 2026, selling an estimated $18.4M and leaving 113,321 shares worth $4.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1392.

Deutsche Bank first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $65.4M in Q2 2023. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Deutsche Bank held 113,321 shares of Novo Nordisk worth $4.16M as of Q1 2026.
  • Deutsche Bank sold 388,518 Novo Nordisk shares in Q1 2026, an estimated $18.4M.
  • Novo Nordisk made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1392 holding.
  • Deutsche Bank first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Novo Nordisk position peaked at $65.4M in Q2 2023.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.